103.55
1.49%
1.525
Dopo l'orario di chiusura:
103.55
0.005
+0.00%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$102.02
Aprire:
$101.93
Volume 24 ore:
94,754
Relative Volume:
0.85
Capitalizzazione di mercato:
$2.34B
Reddito:
$205.62M
Utile/perdita netta:
$37.68M
Rapporto P/E:
85.57
EPS:
1.21
Flusso di cassa netto:
$31.69M
1 W Prestazione:
-1.85%
1M Prestazione:
+15.20%
6M Prestazione:
+31.99%
1 anno Prestazione:
+94.96%
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Nome
Lemaitre Vascular Inc
Settore
Industria
Telefono
781-221-2266
Indirizzo
63 SECOND AVENUE, BURLINGTON, MA
Confronta LMAT con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
LMAT | 103.55 | 2.34B | 205.62M | 37.68M | 31.69M | 1.21 |
ISRG | 531.64 | 190.09B | 7.87B | 2.24B | 586.00M | 4.25 |
BDX | 224.10 | 65.14B | 20.18B | 1.73B | 3.07B | 5.51 |
ALC | 85.81 | 42.44B | 9.76B | 1.16B | 665.00M | 0.72 |
RMD | 239.42 | 34.99B | 4.81B | 1.11B | 1.35B | 6.16 |
WST | 307.21 | 22.29B | 2.88B | 499.60M | 321.60M | 7.41 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-02-06 | Ripresa | KeyBanc Capital Markets | Sector Weight |
2023-10-23 | Iniziato | JMP Securities | Mkt Outperform |
2023-09-06 | Iniziato | Oppenheimer | Outperform |
2023-08-03 | Downgrade | Jefferies | Buy → Hold |
2023-05-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
2022-10-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
2021-09-16 | Iniziato | Jefferies | Buy |
2021-02-12 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2020-03-16 | Aggiornamento | Sidoti | Neutral → Buy |
2019-10-24 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
2019-10-24 | Aggiornamento | Lake Street | Hold → Buy |
2019-10-14 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
2019-07-25 | Reiterato | Barrington Research | Outperform |
2019-07-25 | Aggiornamento | First Analysis Sec | Neutral → Outperform |
2018-10-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
2018-10-08 | Aggiornamento | ROTH Capital | Neutral → Buy |
2018-06-08 | Ripresa | ROTH Capital | Buy |
2018-04-26 | Downgrade | Stifel | Buy → Hold |
2018-04-26 | Aggiornamento | The Benchmark Company | Hold → Buy |
2017-10-27 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
2017-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
2017-07-10 | Downgrade | Canaccord Genuity | Buy → Hold |
2017-07-10 | Downgrade | The Benchmark Company | Buy → Hold |
2017-03-21 | Iniziato | First Analysis Sec | Overweight |
2017-02-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
2016-09-22 | Downgrade | Sidoti | Buy → Neutral |
2016-07-28 | Reiterato | Barrington Research | Outperform |
2016-02-25 | Reiterato | Barrington Research | Outperform |
Mostra tutto
Lemaitre Vascular Inc Borsa (LMAT) Ultime notizie
LeMaitre Vascular director Shadan Martha sells $151,547 in stock - Investing.com
(LMAT) Technical Data - Stock Traders Daily
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stake Raised by Los Angeles Capital Management LLC - MarketBeat
LMATLeMaitre Vascular, Inc. Latest Stock News & Market Updates - StockTitan
LeMaitre Vascular (NASDAQ:LMAT) Sets New 1-Year HighShould You Buy? - MarketBeat
Creative Planning Has $334,000 Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular stock soars to all-time high of $104.33 By Investing.com - Investing.com Australia
Portside Wealth Group LLC Takes Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular stock soars to all-time high of $104.33 - Investing.com India
500: Something went wrong - Investing.com
LeMaitre Vascular Inc (LMAT) Quarterly 10-Q Report - Quartzy
LeMaitre Vascular's SWOT analysis: niche market leader's stock faces valuation scrutiny - Investing.com India
(01/18/21) Top Picks 2021: Avid Technology (AVID) and LeMaitre Vascular (LM - Moneyshow.com
Harbor Capital Advisors Inc. Buys 12,797 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
FY2024 EPS Forecast for LeMaitre Vascular Lifted by Analyst - MarketBeat
LeMaitre Vascular: Market Catching On To Dividend Growth Story (NASDAQ:LMAT) - Seeking Alpha
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Plans Quarterly Dividend of $0.16 - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by F M Investments LLC - MarketBeat
LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Simply Wall St
LeMaitre Vascular Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
LeMaitre Vascular (NASDAQ:LMAT) Hits New 12-Month High Following Earnings Beat - Defense World
LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: R - GuruFocus.com
LeMaitre Vascular (NASDAQ:LMAT) Posts Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
LeMaitre to Participate at Upcoming Investor Conferences in November - GlobeNewswire
Earnings call: LeMaitre Vascular reports robust Q3 growth, plans expansion By Investing.com - Investing.com South Africa
LeMaitre Vascular (NASDAQ:LMAT) Receives "Outperform" Rating from Oppenheimer - MarketBeat
Earnings call: LeMaitre Vascular reports robust Q3 growth, plans expansion - Investing.com
LeMaitre Vascular Inc (LMAT) Trading 12.71% Higher on Nov 1 - GuruFocus.com
Barrington Research Raises LeMaitre Vascular (NASDAQ:LMAT) Price Target to $93.00 - MarketBeat
In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular - Benzinga
LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ... - Yahoo Finance
LeMaitre Vascular (NASDAQ:LMAT) Sets New 52-Week High After Strong Earnings - MarketBeat
LeMaitre Vascular stock target upgraded, keeps buy rating on strong Q3 results - Investing.com UK
Conestoga Capital Advisors LLC Purchases 36,850 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre: Q3 Earnings Snapshot - The Advocate
LeMaitre Vascular (LMAT) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance
LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings: EPS of $0.49 Beats Estimates, Revenue Hits $54.8 Million - GuruFocus.com
LeMaitre Q3 2024 Financial Results - The Manila Times
Congress Asset Management Co. Acquires 18,295 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular Q3 2024 Earnings Preview - MSN
6,169 Shares in LeMaitre Vascular, Inc. (NASDAQ:LMAT) Purchased by Smith Group Asset Management LLC - MarketBeat
Hennion & Walsh Asset Management Inc. Has $1.66 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Centene Stock Rises 29% in a Year: Evaluating the Road Ahead - MSN
Ausbil Investment Management Ltd Has $1.23 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular (LMAT) Set to Announce Earnings on Thursday - MarketBeat
(LMAT) Investment Analysis - Stock Traders Daily
LeMaitre Vascular, Inc. (NASDAQ:LMAT) is Copeland Capital Management LLC's 4th Largest Position - MarketBeat
Insiders At LeMaitre Vascular Sold US$23m In Stock, Alluding To Potential Weakness - Simply Wall St
Lemaitre Vascular Inc Azioni (LMAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):